There’s no training, practice, or test run with cancer. There’s no “Let’s get back to that later.”
So patients, understandably, are asking for help today. We all know testing for cancer earlier is often the right thing to do. And now, we have the technology to help take action. Join us, not only in trying to impact lives, but in our shared goal of defining the future of patient-first care.
The Galleri test is a groundbreaking and potentially life-changing advancement in cancer detection for adults with an elevated risk for cancer, such as those aged 50 or older.
With the Galleri test, patients could receive the benefits of early detection of multiple cancers through a simple blood draw.
50+ cancer types detected
including cancers not routinely screened for7,8
0.5% false-positive rate
to help minimize unnecessary medical procedures7
in predicting the location of the cancer, directing diagnostic workup7
We are experts in implementing complex partnerships and are charged to find inflection points in alignment with your health system’s goals. From improving population health via data analytics and clinical partnerships, to focusing on shared strategies in education and commercialization, we’re built for collaboration.
Please check your inbox. You must confirm your subscription to receive emails for the Galleri test.
Important safety information
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of“Cancer Signal Not Detected” does not rule out cancer. A test result of“Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer. If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
Laboratory / test information
GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.